1019 related articles for article (PubMed ID: 17470865)
21. Relationship between FDG uptake and the pathological risk category in gastrointestinal stromal tumors.
Otomi Y; Otsuka H; Morita N; Terazawa K; Furutani K; Harada M; Nishitani H
J Med Invest; 2010 Aug; 57(3-4):270-4. PubMed ID: 20847527
[TBL] [Abstract][Full Text] [Related]
22. Assessment of gastrointestinal stromal tumors with computed tomography following treatment with imatinib mesylate.
Phongkitkarun S; Phaisanphrukkun C; Jatchavala J; Sirachainan E
World J Gastroenterol; 2008 Feb; 14(6):892-8. PubMed ID: 18240346
[TBL] [Abstract][Full Text] [Related]
23. [Role of FDG PET in the staging, recurrence and treatment response to imatinib (Glivec) in patients with gastrointestinal stromal tumors].
Simó Perdigó M; García Garzón JR; Soler Peter M; Pérez Moure G; López Gandul S; Lomeña Caballero FJ
Rev Esp Med Nucl; 2006; 25(2):80-8. PubMed ID: 16759613
[TBL] [Abstract][Full Text] [Related]
24. Imaging of gastrointestinal stromal tumors before and after imatinib mesylate therapy.
Shankar S; Dundamadappa SK; Karam AR; Stay RM; van Sonnenberg E
Acta Radiol; 2009 Oct; 50(8):837-44. PubMed ID: 19735005
[TBL] [Abstract][Full Text] [Related]
25. [Early response to treatment with Glivec detected with 18F-FDG PET in a patient with gastrointestinal stromal tumor].
Delgado Bolton RC; Ortega Candil A; Pérez Castejón MJ; Garcerant M; Cabrera Martín MN; Lapeña Gutiérrez L; Carreras Delgado JL
Rev Esp Med Nucl; 2008; 27(2):112-7. PubMed ID: 18367049
[TBL] [Abstract][Full Text] [Related]
26. PET scanning evaluation of response to imatinib mesylate therapy in gastrointestinal stromal tumor (GIST) patients.
Gelibter A; Milella M; Ceribelli A; Zeuli M; Ferraresi V; Vecchione A; Cognetti F
Anticancer Res; 2004; 24(5B):3147-51. PubMed ID: 15510603
[TBL] [Abstract][Full Text] [Related]
27. Metabolic response by FDG-PET to imatinib correlates with exon 11 KIT mutation and predicts outcome in patients with mucosal melanoma.
Zukotynski K; Yap JT; Giobbie-Hurder A; Weber J; Gonzalez R; Gajewski TF; O'Day S; Kim K; Hodi FS; Van den Abbeele AD
Cancer Imaging; 2014 Nov; 14(1):30. PubMed ID: 25609545
[TBL] [Abstract][Full Text] [Related]
28. Comparison of PET, CT, and dual-modality PET/CT imaging for monitoring of imatinib (STI571) therapy in patients with gastrointestinal stromal tumors.
Antoch G; Kanja J; Bauer S; Kuehl H; Renzing-Koehler K; Schuette J; Bockisch A; Debatin JF; Freudenberg LS
J Nucl Med; 2004 Mar; 45(3):357-65. PubMed ID: 15001674
[TBL] [Abstract][Full Text] [Related]
29. The value of PET, CT and in-line PET/CT in patients with gastrointestinal stromal tumours: long-term outcome of treatment with imatinib mesylate.
Goerres GW; Stupp R; Barghouth G; Hany TF; Pestalozzi B; Dizendorf E; Schnyder P; Luthi F; von Schulthess GK; Leyvraz S
Eur J Nucl Med Mol Imaging; 2005 Feb; 32(2):153-62. PubMed ID: 15690223
[TBL] [Abstract][Full Text] [Related]
30. Follow-up of hepatic and peritoneal metastases of gastrointestinal tumors (GIST) under Imatinib therapy requires different criteria of radiological evaluation (size is not everything!!!).
Mabille M; Vanel D; Albiter M; Le Cesne A; Bonvalot S; Le Péchoux C; Terrier P; Shapeero LG; Dromain C
Eur J Radiol; 2009 Feb; 69(2):204-8. PubMed ID: 19046841
[TBL] [Abstract][Full Text] [Related]
31. Imatinib mesylate for the treatment of gastrointestinal stromal tumours: best monitored with FDG PET.
Jager PL; Gietema JA; van der Graaf WT
Nucl Med Commun; 2004 May; 25(5):433-8. PubMed ID: 15100500
[TBL] [Abstract][Full Text] [Related]
32. [Utility of FDG-PET for early evaluation of efficiency of imatinib mesylate (Glivec) in the treatment of gastrointestinal stromal tumors].
García-González J; Sánchez Salmón A; Areses Manrique C; León Mateos L; Barandela Salgado J; López López R
Rev Esp Med Nucl; 2007; 26(2):100-2. PubMed ID: 17386236
[TBL] [Abstract][Full Text] [Related]
33. Early response assessment in gastrointestinal stromal tumors with FDG PET scan 24 hours after a single dose of imatinib.
Shinto A; Nair N; Dutt A; Baghel NS
Clin Nucl Med; 2008 Jul; 33(7):486-7. PubMed ID: 18580237
[TBL] [Abstract][Full Text] [Related]
34. 18FDG-Positron emission tomography for the early prediction of response in advanced soft tissue sarcoma treated with imatinib mesylate (Glivec).
Stroobants S; Goeminne J; Seegers M; Dimitrijevic S; Dupont P; Nuyts J; Martens M; van den Borne B; Cole P; Sciot R; Dumez H; Silberman S; Mortelmans L; van Oosterom A
Eur J Cancer; 2003 Sep; 39(14):2012-20. PubMed ID: 12957455
[TBL] [Abstract][Full Text] [Related]
35. FDG PET and FDG PET/CT in patients with gastrointestinal stromal tumours.
Malle P; Sorschag M; Gallowitsch HJ
Wien Med Wochenschr; 2012 Oct; 162(19-20):423-9. PubMed ID: 22890522
[TBL] [Abstract][Full Text] [Related]
36. Assessment of early response to imatinib 800 mg after 400 mg progression by ¹⁸F-fluorodeoxyglucose PET in patients with metastatic gastrointestinal stromal tumors.
Chacón M; Eleta M; Espindola AR; Roca E; Méndez G; Rojo S; Pupareli C
Future Oncol; 2015; 11(6):953-64. PubMed ID: 25760976
[TBL] [Abstract][Full Text] [Related]
37. [Imatinib mesylate (glivec) as a treatment for gastrointestinal stromal tumor (GIST)--long term follow-up].
Raccah E; Merimsky O; Kuten A; Apter S; Catane R
Harefuah; 2007 May; 146(5):329-34, 408. PubMed ID: 17674545
[TBL] [Abstract][Full Text] [Related]
38. 18F-Fluorodeoxyglucose positron emission tomography in evaluating treatment response to imatinib or other drugs in gastrointestinal stromal tumors: a systematic review.
Treglia G; Mirk P; Stefanelli A; Rufini V; Giordano A; Bonomo L
Clin Imaging; 2012; 36(3):167-75. PubMed ID: 22542374
[TBL] [Abstract][Full Text] [Related]
39. New strategies for treating GIST when imatinib fails.
Boyar MS; Taub RN
Cancer Invest; 2007 Aug; 25(5):328-35. PubMed ID: 17661208
[TBL] [Abstract][Full Text] [Related]
40. Patterns of progression in gastrointestinal stromal tumor treated with imatinib mesylate.
Ryu MH; Lee JL; Chang HM; Kim TW; Kang HJ; Sohn HJ; Lee JS; Kang YK
Jpn J Clin Oncol; 2006 Jan; 36(1):17-24. PubMed ID: 16418188
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
